日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

粪便微生物移植联合免疫疗法治疗非小细胞肺癌和黑色素瘤：FMT-LUMINate II期试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04186-5
Duttagupta, Sreya; Messaoudene, Meriem; Hunter, Sebastian; Desilets, Antoine; Jamal, Rahima; Mihalcioiu, Catalin; Belkaid, Wiam; Marcoux, Nicolas; Fidelle, Marine; Suissa, Deborah; Ponce, Mayra; Geiger, Mallia; Malo, Julie; Piccinno, Gianmarco; Punčochář, Michal; Filin, Alysé; Heidrich, Vitor; Rusu, Diana; Mbaye, Babacar; Durand, Sylvere; Ben Aissa, Imen; Puller, Vadim; de Lahondès, Raynald; Blais, Normand; Tehfe, Mustapha; Owen, Scott; Bélanger, Karl; Parvathy, Seema Nair; Shieh, Benjamin; Raphael, Jacques; Lenehan, John; Breadner, Daniel; Rothenstein, Jeffrey; Rozza, Nicholas; Maillou, Jade; Nili, Somayeh; Prifti, Diogjena Katerina; Pinto, Federica; Armanini, Federica; Kim-Schulze, Seunghee; Marron, Thomas U; Kroemer, Guido; Derosa, Lisa; Zitvogel, Laurence; Silverman, Michael; Segata, Nicola; Maleki Vareki, Saman; Routy, Bertrand; Elkrief, Arielle
黑色素瘤
肺癌
肿瘤
肿瘤免疫
微生物学
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients

对全切片图像进行计算分析可预测接受免疫治疗的非小细胞肺癌患者的PD-L1表达和无进展生存期

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06487-2
Dia, Abdou Khadir; Kolnohuz, Alona; Yolchuyeva, Sevinj; Tonneau, Marion; Lamaze, Fabien; Orain, Michele; Gagné, Andréanne; Blais, Florence; Coulombe, François; Malo, Julie; Belkaid, Wiam; Elkrief, Arielle; Williamson, Drew; Routy, Bertrand; Joubert, Philippe; Laplante, Mathieu; Bilodeau, Steve; Manem, Venkata Sk
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors

结合培养组学和宏基因组测序技术，对接受免疫检查点抑制剂治疗的癌症患者的肠道微生物组进行表征

期刊:Gut Pathogens
影响因子:4
doi:10.1186/s13099-025-00694-4
Diop, Khoudia; Mbaye, Babacar; Nili, Somayeh; Filin, Alysé; Benlaifaoui, Myriam; Malo, Julie; Renaud, Anne Sophie; Belkaid, Wiam; Hunter, Sebastian; Messaoudene, Meriem; Lee, Karla A; Elkrief, Arielle; Routy, Bertrand
肿瘤
肿瘤免疫
微生物学
Sequencing
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study)

液体活检在真实世界环境中对 EGFR 突变型晚期肺癌患者早期诊断的临床应用价值（CLEAR 研究）

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32020057
Samaha, Ramy; El Sayed, Rola; Alameddine, Raafat; Florescu, Marie; Tehfe, Mustapha; Routy, Bertrand; Elkrief, Arielle; Belkaid, Wiam; Desilets, Antoine; Weng, Xiaoduan; Nassabein, Rami; Blanc-Durand, Félix; Kenth, Gurvinder; Kasymjanova, Goulnar; Agulnik, Jason; Blais, Normand
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
发表日期：2025
文献求助 收藏

Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma

抗生素暴露不影响晚期黑色素瘤患者接受抗BRAF/抗MEK靶向治疗的疗效

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32110630
Wang, Yu Shi; Wang, Qing Yin; Moise, Alexia Erika; Syed, Hamida Claudia; Malo, Julie; Soberano, Spencer; Belkaid, Wiam; Messaoudene, Meriem; Bélanger, Karl; Desilets, Antoine; Jamal, Rahima; Routy, Bertrand; Elkrief, Arielle
黑色素瘤
BRAF
发表日期：2025
文献求助 收藏

Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics

利用放射组学对接受一线免疫治疗的非小细胞肺癌患者的生存结果进行多中心预后建模

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-04854-z
Yolchuyeva, Sevinj; Ebrahimpour, Leyla; Tonneau, Marion; Lamaze, Fabien; Orain, Michele; Coulombe, François; Malo, Julie; Belkaid, Wiam; Routy, Bertrand; Joubert, Philippe; Manem, Venkata Sk
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study

免疫治疗非小细胞肺癌患者病理组学和放射组学特征的跨尺度关联：一项初步研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16020348
Dia, Abdou Khadir; Ebrahimpour, Leyla; Yolchuyeva, Sevinj; Tonneau, Marion; Lamaze, Fabien C; Orain, Michèle; Coulombe, Francois; Malo, Julie; Belkaid, Wiam; Routy, Bertrand; Joubert, Philippe; Després, Philippe; Manem, Venkata S K
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC.

CRYOVATE：肺癌冷冻激活联合免疫疗法治疗晚期非小细胞肺癌的试点研究

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100737
Desilets Antoine, Pinheiro Gabryella, Belkaid Wiam, Salko Olivier, Malo Julie, Zarour Eleyine, Jouquan Adeline, Thibaudeau Anne-Julie, Nolin Marc-Antoine, Stagg John, Florescu Marie, Tehfe Mustapha, Blais Normand, Tabchi Samer, Chalaoui Jean, Stephenson Philippe, Elkrief Arielle, Trinh Vincent Quoc-Huy, Routy Bertrand, Liberman Moishe
细胞生物学
肺癌
发表日期：2024
文献求助 收藏

A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study

放射组学-临床模型预测接受免疫疗法治疗的非小细胞肺癌患者的总生存期：一项多中心研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15153829
Yolchuyeva, Sevinj; Giacomazzi, Elena; Tonneau, Marion; Ebrahimpour, Leyla; Lamaze, Fabien C; Orain, Michele; Coulombe, François; Malo, Julie; Belkaid, Wiam; Routy, Bertrand; Joubert, Philippe; Manem, Venkata S K
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study

基于影像生物标志物的预测晚期非小细胞肺癌患者接受纳武利尤单抗和帕博利珠单抗治疗后程序性死亡配体1表达及生存结局：一项多中心研究

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100602
Yolchuyeva, Sevinj; Giacomazzi, Elena; Tonneau, Marion; Lamaze, Fabien; Orain, Michele; Coulombe, François; Malo, Julie; Belkaid, Wiam; Routy, Bertrand; Joubert, Philippe; Manem, Venkata S K
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏